On Monday, Plexus got an upgrade to its Relative Strength (RS) Rating, from 70 to 73.
This proprietary rating tracks technical performance by using a 1 (worst) to 99 (best) score that shows how a stock's price action over the trailing 52 weeks stacks up against all the other stocks in our database.
Over 100 years of market history shows that the best-performing stocks typically have an RS Rating north of 80 in the early stages of their moves. See if Plexus can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Plexus is not currently near a potential buying area. See if the stock goes on to build a promising consolidation that could ignite a new run.
Plexus reported negative growth for both sales and earnings last quarter. Plexus is expected to report its next quarterly numbers on or around Jul. 17.
Plexus earns the No. 8 rank among its peers in the Electronics-Contract Manufacturing industry group. Celestica, Fabrinet and TTM Technologies are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
